Nuvation Bio

Filed a patent for "combination treatment of cancers with a bet inhibitor" on Thu, December 22, 2022

Filed a patent for "combination treatment of cancers with a bet inhibitor" on Thu, April 13, 2023

Filed a patent for "anti-cancer nuclear hormone receptor-targeting compounds" on Wed, September 28, 2022

Filed a patent for "anti-cancer nuclear hormone receptor-targeting compounds" on Wed, November 2, 2022

Filed a patent for "anti-cancer nuclear hormone receptor-targeting compounds" on Thu, April 20, 2023

Filed a patent for "anti-cancer nuclear hormone receptor-targeting compounds" on Thu, December 1, 2022

Filed a patent for "substituted pyrazolo[3,4-d]pyrimidines as wee1 inhibitors" on Thu, April 20, 2023